A Multicenter Retrospective Study on the Clinical Course of Smoldering Multiple Myeloma(SMM) Patients in Asia
Not Applicable
- Conditions
- Smoldering multiple myeloma
- Registration Number
- JPRN-UMIN000019059
- Lead Sponsor
- Sapporo Medical University School of MedicineDepartment Gastroenterology, Rheumatology and Clinical Immunol
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
symptomatic multiple myeloma
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method High-risk factors in Asian SMM patients (The high-risk factor or the combination of high-risk factors that 60% of SMM patients progress for symptomatic myeloma within two years)
- Secondary Outcome Measures
Name Time Method 1.Periods from SMM to symptomatic myeloma 2.Progress rate to symptomatic myeloma at two and five years after the diagnosis of SMM 3.Five-year overall survival rate from the diagnosis of SMM 4.Overall survival of SMM